SEC Form 4 · accession 0001209191-15-051462
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Don C Stark
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2015 | S | 5,732 | $4.1417 | D | 30,450 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in Column 4 is a weighted average price. The sale prices in this transaction were $4.143 for 300 shares, $4.147 for 1,200 shares and $4.1401 for 4,232 shares.